Skip to main content
Top
Published in: Immunity & Ageing 1/2011

Open Access 01-12-2011 | Review

Immunopathogenesis of primary biliary cirrhosis: an old wives' tale

Authors: Daniel S Smyk, Eirini I Rigopoulou, Ana Lleo, Robin D Abeles, Athanasios Mavropoulos, Charalambos Billinis, Pietro Invernizzi, Dimitrios P Bogdanos

Published in: Immunity & Ageing | Issue 1/2011

Login to get access

Abstract

Primary biliary cirrhosis (PBC) is a cholestatic liver disease characterised by the autoimmune destruction of the small intrahepatic bile ducts. The disease has an unpredictable clinical course, but may progress to fibrosis and cirrhosis. Although medical treatment with urseodeoxycholic acid is largely successful, some patients may progress to liver failure requiring liver transplantation. PBC is characterised by the presence of disease specific anti-mitochondrial (AMA) antibodies, which are pathognomonic for PBC development. The disease demonstrates an overwhelming female preponderance and virtually all women with PBC present in middle age. The reasons for this are unknown; however several environmental and immunological factors may be involved. As the immune systems ages, it become less self tolerant, and mounts a weaker response to pathogens, possibly leading to cross reactivity or molecular mimicry. Some individuals display immunological changes which encourage the development of autoimmune disease. Risk factors implicated in PBC include recurrent urinary tract infection in females, as well as an increased prevalence of reproductive complications. These risk factors may work in concert with and possibly even accelerate, immune system ageing, contributing to PBC development. This review will examine the changes that occur in the immune system with ageing, paying particular attention to those changes which contribute to the development of autoimmune disease with increasing age. The review also discusses risk factors which may account for the increased female predominance of PBC, such as recurrent UTI and oestrogens.
Literature
3.
go back to reference Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ: Primary biliary cirrhosis. Hepatology. 2009, 50: 291-308.PubMedCrossRef Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ: Primary biliary cirrhosis. Hepatology. 2009, 50: 291-308.PubMedCrossRef
4.
go back to reference Selmi C, Invernizzi P, Keeffe EB, Coppel RL, Podda M, Rossaro L, Ansari AA, Gershwin ME: Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol. 2004, 38: 264-271.PubMedCrossRef Selmi C, Invernizzi P, Keeffe EB, Coppel RL, Podda M, Rossaro L, Ansari AA, Gershwin ME: Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol. 2004, 38: 264-271.PubMedCrossRef
5.
go back to reference Bogdanos DP, Baum H, Vergani D: Antimitochondrial and other autoantibodies. Clin Liver Dis. 2003, 7: 759-777, vi.PubMedCrossRef Bogdanos DP, Baum H, Vergani D: Antimitochondrial and other autoantibodies. Clin Liver Dis. 2003, 7: 759-777, vi.PubMedCrossRef
6.
go back to reference Bogdanos DP, Invernizzi P, Mackay IR, Vergani D: Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol. 2008, 14: 3374-3387.PubMedCentralPubMedCrossRef Bogdanos DP, Invernizzi P, Mackay IR, Vergani D: Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol. 2008, 14: 3374-3387.PubMedCentralPubMedCrossRef
7.
go back to reference Bogdanos DP, Komorowski L: Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta. 2011, 412: 502-512.PubMedCrossRef Bogdanos DP, Komorowski L: Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta. 2011, 412: 502-512.PubMedCrossRef
9.
go back to reference Liaskos C, Bogdanos DP, Rigopoulou EI, Dalekos GN: Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact?. J Gastroenterol Hepatol. 2007, 22: 454-455.PubMedCrossRef Liaskos C, Bogdanos DP, Rigopoulou EI, Dalekos GN: Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact?. J Gastroenterol Hepatol. 2007, 22: 454-455.PubMedCrossRef
10.
go back to reference Liaskos C, Bogdanos DP, Davies ET, Dalekos GN: Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis. J Clin Pathol. 2007, 60: 107-108.PubMedCentralPubMedCrossRef Liaskos C, Bogdanos DP, Davies ET, Dalekos GN: Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis. J Clin Pathol. 2007, 60: 107-108.PubMedCentralPubMedCrossRef
11.
go back to reference Dalekos GN, Bogdanos DP, Neuberger J: Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message?. Liver Int. 2008, 28: 426-428.PubMedCrossRef Dalekos GN, Bogdanos DP, Neuberger J: Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message?. Liver Int. 2008, 28: 426-428.PubMedCrossRef
12.
go back to reference Bernal W, Meda F, Ma Y, Bogdanos DP, Vergani D: Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience. Hepatology. 2008, 47: 1096-1097. author reply 1097PubMedCrossRef Bernal W, Meda F, Ma Y, Bogdanos DP, Vergani D: Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience. Hepatology. 2008, 47: 1096-1097. author reply 1097PubMedCrossRef
13.
go back to reference Bogdanos DP, Mieli-Vergani G, Vergani D: Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis. 2009, 29: 241-253.PubMedCrossRef Bogdanos DP, Mieli-Vergani G, Vergani D: Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis. 2009, 29: 241-253.PubMedCrossRef
14.
go back to reference Bogdanos DP, Mieli-Vergani G, Vergani D: Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter?. Clin Infect Dis. 2005, 40: 508-510.PubMedCrossRef Bogdanos DP, Mieli-Vergani G, Vergani D: Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter?. Clin Infect Dis. 2005, 40: 508-510.PubMedCrossRef
15.
go back to reference Bogdanos DP, Mieli-Vergani G, Vergani D: Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. Clin Infect Dis. 2004, 38: 1505-author reply 1505-1506PubMedCrossRef Bogdanos DP, Mieli-Vergani G, Vergani D: Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. Clin Infect Dis. 2004, 38: 1505-author reply 1505-1506PubMedCrossRef
16.
go back to reference Bogdanos DP, Gilbert D, Bianchi I, Leoni S, Mitry RR, Ma Y, Mieli-Vergani G, Vergani D: Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J Autoimmune Dis. 2004, 1: 4-PubMedCentralPubMedCrossRef Bogdanos DP, Gilbert D, Bianchi I, Leoni S, Mitry RR, Ma Y, Mieli-Vergani G, Vergani D: Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J Autoimmune Dis. 2004, 1: 4-PubMedCentralPubMedCrossRef
17.
go back to reference Bogdanos DP, Bianchi I, Ma Y, Mitry RR, Mieli-Vergani G, Vergani D: Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin Chem. 2004, 50: 682-683. author reply 683-684PubMedCrossRef Bogdanos DP, Bianchi I, Ma Y, Mitry RR, Mieli-Vergani G, Vergani D: Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin Chem. 2004, 50: 682-683. author reply 683-684PubMedCrossRef
18.
go back to reference Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PS, Dickson ER, Homburger HA: Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology. 1997, 25: 6-11.PubMedCrossRef Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PS, Dickson ER, Homburger HA: Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology. 1997, 25: 6-11.PubMedCrossRef
19.
go back to reference Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D: Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut. 2005, 54: 528-532.PubMedCentralPubMedCrossRef Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D: Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut. 2005, 54: 528-532.PubMedCentralPubMedCrossRef
20.
go back to reference Rigopoulou EI, Davies ET, Bogdanos DP, Liaskos C, Mytilinaiou M, Koukoulis GK, Dalekos GN, Vergani D: Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int. 2007, 27: 1226-1231.PubMedCrossRef Rigopoulou EI, Davies ET, Bogdanos DP, Liaskos C, Mytilinaiou M, Koukoulis GK, Dalekos GN, Vergani D: Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int. 2007, 27: 1226-1231.PubMedCrossRef
21.
go back to reference Rigopoulou EI, Bogdanos DP, Liaskos C, Koutsoumpas A, Baum H, Vergani D, Dalekos GN: Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta. 2007, 380: 118-121.PubMedCrossRef Rigopoulou EI, Bogdanos DP, Liaskos C, Koutsoumpas A, Baum H, Vergani D, Dalekos GN: Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta. 2007, 380: 118-121.PubMedCrossRef
22.
go back to reference Vergani D, Longhi MS, Bogdanos DP, Ma Y, Mieli-Vergani G: Autoimmune hepatitis. Semin Immunopathol. 2009, 31: 421-435.PubMedCrossRef Vergani D, Longhi MS, Bogdanos DP, Ma Y, Mieli-Vergani G: Autoimmune hepatitis. Semin Immunopathol. 2009, 31: 421-435.PubMedCrossRef
23.
go back to reference Hannam S, Bogdanos DP, Davies ET, Hussain MJ, Portmann BC, Mieli-Vergani G, Vergani D: Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies. Autoimmunity. 2002, 35: 545-550.PubMedCrossRef Hannam S, Bogdanos DP, Davies ET, Hussain MJ, Portmann BC, Mieli-Vergani G, Vergani D: Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies. Autoimmunity. 2002, 35: 545-550.PubMedCrossRef
24.
go back to reference Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, Underhill J, Durr R, Mieli-Vergani G, Vergani D: Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002, 35: 658-664.PubMedCrossRef Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, Underhill J, Durr R, Mieli-Vergani G, Vergani D: Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002, 35: 658-664.PubMedCrossRef
25.
go back to reference Bogdanos D, Pusl T, Rust C, Vergani D, Beuers U: Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol. 2008, 49: 466-473.PubMedCrossRef Bogdanos D, Pusl T, Rust C, Vergani D, Beuers U: Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol. 2008, 49: 466-473.PubMedCrossRef
26.
go back to reference Dahnrich C, Pares A, Caballeria L, Rosemann A, Schlumberger W, Probst C, Mytilinaiou M, Bogdanos D, Vergani D, Stocker W, Komorowski L: New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem. 2009, 55: 978-985.PubMedCrossRef Dahnrich C, Pares A, Caballeria L, Rosemann A, Schlumberger W, Probst C, Mytilinaiou M, Bogdanos D, Vergani D, Stocker W, Komorowski L: New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem. 2009, 55: 978-985.PubMedCrossRef
27.
go back to reference Gabeta S, Norman GL, Liaskos C, Papamichalis PA, Zografos T, Garagounis A, Rigopoulou EI, Dalekos GN: Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol. 2007, 27: 378-387.PubMedCrossRef Gabeta S, Norman GL, Liaskos C, Papamichalis PA, Zografos T, Garagounis A, Rigopoulou EI, Dalekos GN: Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol. 2007, 27: 378-387.PubMedCrossRef
28.
go back to reference Vergani D, Bogdanos DP: Positive markers in AMA-negative PBC. Am J Gastroenterol. 2003, 98: 241-243.PubMedCrossRef Vergani D, Bogdanos DP: Positive markers in AMA-negative PBC. Am J Gastroenterol. 2003, 98: 241-243.PubMedCrossRef
29.
go back to reference Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF: Natural history of early primary biliary cirrhosis. Lancet. 1996, 348: 1399-1402.PubMedCrossRef Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF: Natural history of early primary biliary cirrhosis. Lancet. 1996, 348: 1399-1402.PubMedCrossRef
30.
go back to reference Mitchison HC, Bassendine MF, Hendrick A, Bennett MK, Bird G, Watson AJ, James OF: Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?. Hepatology. 1986, 6: 1279-1284.PubMedCrossRef Mitchison HC, Bassendine MF, Hendrick A, Bennett MK, Bird G, Watson AJ, James OF: Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?. Hepatology. 1986, 6: 1279-1284.PubMedCrossRef
31.
go back to reference Bogdanos DP, Liaskos C, Rigopoulou EI, Dalekos GN: Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta. 2006, 373: 183-184. author reply 185PubMedCrossRef Bogdanos DP, Liaskos C, Rigopoulou EI, Dalekos GN: Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta. 2006, 373: 183-184. author reply 185PubMedCrossRef
32.
go back to reference Bogdanos DP, Pares A, Rodes J, Vergani D: Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. The American journal of gastroenterology. 2004, 99: 763-764. author reply 765PubMedCrossRef Bogdanos DP, Pares A, Rodes J, Vergani D: Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. The American journal of gastroenterology. 2004, 99: 763-764. author reply 765PubMedCrossRef
33.
go back to reference Gershwin ME, Mackay IR: Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology. 1991, 100: 822-833.PubMed Gershwin ME, Mackay IR: Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology. 1991, 100: 822-833.PubMed
34.
go back to reference Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, Liu S, Roche TE, Krams SM, Munoz S, Gershwin ME: Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med. 1995, 181: 723-733.PubMedCrossRef Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, Liu S, Roche TE, Krams SM, Munoz S, Gershwin ME: Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med. 1995, 181: 723-733.PubMedCrossRef
35.
go back to reference Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, Gershwin ME: In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology. 1997, 25: 791-796.PubMedCrossRef Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, Gershwin ME: In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology. 1997, 25: 791-796.PubMedCrossRef
36.
go back to reference Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME: IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun. 2006, 27: 50-53.PubMedCrossRef Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME: IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun. 2006, 27: 50-53.PubMedCrossRef
37.
go back to reference Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ, Bain VG: Pediatric-onset primary biliary cirrhosis. Gastroenterology. 2003, 125: 1476-1479.PubMedCrossRef Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ, Bain VG: Pediatric-onset primary biliary cirrhosis. Gastroenterology. 2003, 125: 1476-1479.PubMedCrossRef
38.
go back to reference Gregorio GV, Portmann B, Mowat AP, Vergani D, Mieli-Vergani G: A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis. J Hepatol. 1997, 27: 751-754.PubMedCrossRef Gregorio GV, Portmann B, Mowat AP, Vergani D, Mieli-Vergani G: A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis. J Hepatol. 1997, 27: 751-754.PubMedCrossRef
39.
go back to reference Melegh B, Skuta G, Pajor L, Hegedus G, Sumegi B: Autoantibodies against subunits of pyruvate dehydrogenase and citrate synthase in a case of paediatric biliary cirrhosis. Gut. 1998, 42: 753-756.PubMedCentralPubMedCrossRef Melegh B, Skuta G, Pajor L, Hegedus G, Sumegi B: Autoantibodies against subunits of pyruvate dehydrogenase and citrate synthase in a case of paediatric biliary cirrhosis. Gut. 1998, 42: 753-756.PubMedCentralPubMedCrossRef
40.
go back to reference Tsuda M, Torgerson TR, Selmi C, Gambineri E, Carneiro-Sampaio M, Mannurita SC, Leung PS, Norman GL, Gershwin ME: The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun. 2010, 35: 265-268.PubMedCrossRef Tsuda M, Torgerson TR, Selmi C, Gambineri E, Carneiro-Sampaio M, Mannurita SC, Leung PS, Norman GL, Gershwin ME: The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun. 2010, 35: 265-268.PubMedCrossRef
41.
go back to reference Zamfir O, Briaud I, Dubel L, Ballot E, Johanet C: Anti-pyruvate dehydrogenase autoantibodies in extrahepatic disorders. J Hepatol. 1999, 31: 964-965.PubMedCrossRef Zamfir O, Briaud I, Dubel L, Ballot E, Johanet C: Anti-pyruvate dehydrogenase autoantibodies in extrahepatic disorders. J Hepatol. 1999, 31: 964-965.PubMedCrossRef
42.
go back to reference Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, Vergani D: Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology. 2007, 46: 472-484.PubMedCrossRef Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, Vergani D: Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology. 2007, 46: 472-484.PubMedCrossRef
43.
go back to reference Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D: Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006, 130: 868-882.PubMedCrossRef Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D: Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006, 130: 868-882.PubMedCrossRef
44.
go back to reference Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, Mieli-Vergani G, Vergani D: Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun. 2005, 25: 63-71.PubMedCrossRef Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, Mieli-Vergani G, Vergani D: Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun. 2005, 25: 63-71.PubMedCrossRef
45.
go back to reference Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D: Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004, 41: 31-37.PubMedCrossRef Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D: Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004, 41: 31-37.PubMedCrossRef
46.
go back to reference Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y, Tsuneyama K, Nakamura M, Komori A: Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology. 2008, 47: 958-965.PubMedCrossRef Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y, Tsuneyama K, Nakamura M, Komori A: Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology. 2008, 47: 958-965.PubMedCrossRef
47.
go back to reference Selmi C, Gershwin ME: Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol. 2004, 16: 406-410.PubMedCrossRef Selmi C, Gershwin ME: Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol. 2004, 16: 406-410.PubMedCrossRef
48.
go back to reference Selmi C, Mackay IR, Gershwin ME: The immunological milieu of the liver. Semin Liver Dis. 2007, 27: 129-139.PubMedCrossRef Selmi C, Mackay IR, Gershwin ME: The immunological milieu of the liver. Semin Liver Dis. 2007, 27: 129-139.PubMedCrossRef
49.
go back to reference Selmi C, Meda F, Kasangian A, Invernizzi P, Tian Z, Lian Z, Podda M, Gershwin ME: Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol. 2010, 7: 1-10.PubMedCentralPubMedCrossRef Selmi C, Meda F, Kasangian A, Invernizzi P, Tian Z, Lian Z, Podda M, Gershwin ME: Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol. 2010, 7: 1-10.PubMedCentralPubMedCrossRef
50.
go back to reference Hirschfield GM, Invernizzi P: Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis. 2011, 31: 147-156.PubMedCrossRef Hirschfield GM, Invernizzi P: Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis. 2011, 31: 147-156.PubMedCrossRef
51.
go back to reference Hirschfield GM, Heathcote EJ, Gershwin ME: Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology. 2010, 139: 1481-1496.PubMedCrossRef Hirschfield GM, Heathcote EJ, Gershwin ME: Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology. 2010, 139: 1481-1496.PubMedCrossRef
52.
go back to reference Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M: Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol. 2004, 172: 6444-6452.PubMedCrossRef Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M: Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol. 2004, 172: 6444-6452.PubMedCrossRef
53.
go back to reference Van de Water J, Turchany J, Leung PS, Lake J, Munoz S, Surh CD, Coppel R, Ansari A, Nakanuma Y, Gershwin ME: Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest. 1993, 91: 2653-2664.PubMedCentralPubMedCrossRef Van de Water J, Turchany J, Leung PS, Lake J, Munoz S, Surh CD, Coppel R, Ansari A, Nakanuma Y, Gershwin ME: Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest. 1993, 91: 2653-2664.PubMedCentralPubMedCrossRef
54.
go back to reference Van de Water J, Ishibashi H, Coppel RL, Gershwin ME: Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology. 2001, 33: 771-775.PubMedCrossRef Van de Water J, Ishibashi H, Coppel RL, Gershwin ME: Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology. 2001, 33: 771-775.PubMedCrossRef
55.
go back to reference Koutsoumpas A, Polymeros D, Tsiamoulos Z, Smyk D, Karamanolis G, Triantafyllou K, Rigopoulou EI, Forbes A, Vergani D, Bogdanos DP, Ladas SD: Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. J Crohns Colitis. 2011, 5: 101-109.PubMedCrossRef Koutsoumpas A, Polymeros D, Tsiamoulos Z, Smyk D, Karamanolis G, Triantafyllou K, Rigopoulou EI, Forbes A, Vergani D, Bogdanos DP, Ladas SD: Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. J Crohns Colitis. 2011, 5: 101-109.PubMedCrossRef
56.
go back to reference Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A: Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?. Gastroenterology. 2006, 131: 85-96.PubMedCrossRef Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A: Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?. Gastroenterology. 2006, 131: 85-96.PubMedCrossRef
57.
go back to reference Koutsoumpas A, Mytilinaiou M, Polymeros D, Dalekos GN, Bogdanos DP: Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol. 2009, 21: 1220-PubMedCrossRef Koutsoumpas A, Mytilinaiou M, Polymeros D, Dalekos GN, Bogdanos DP: Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol. 2009, 21: 1220-PubMedCrossRef
58.
go back to reference Bogdanos DP, Choudhuri K, Vergani D: Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver. 2001, 21: 225-232.PubMedCrossRef Bogdanos DP, Choudhuri K, Vergani D: Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver. 2001, 21: 225-232.PubMedCrossRef
59.
go back to reference Bogdanos DP, Mieli-Vergani G, Vergani D: Virus, liver and autoimmunity. Dig Liver Dis. 2000, 32: 440-446.PubMedCrossRef Bogdanos DP, Mieli-Vergani G, Vergani D: Virus, liver and autoimmunity. Dig Liver Dis. 2000, 32: 440-446.PubMedCrossRef
60.
go back to reference Wen L, Ma Y, Bogdanos DP, Wong FS, Demaine A, Mieli-Vergani G, Vergani D: Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr Mol Med. 2001, 1: 379-389.PubMedCrossRef Wen L, Ma Y, Bogdanos DP, Wong FS, Demaine A, Mieli-Vergani G, Vergani D: Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr Mol Med. 2001, 1: 379-389.PubMedCrossRef
61.
go back to reference Corpechot C, Chretien Y, Chazouilleres O, Poupon R: Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. Journal of hepatology. 2010, 53: 162-169.PubMedCrossRef Corpechot C, Chretien Y, Chazouilleres O, Poupon R: Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. Journal of hepatology. 2010, 53: 162-169.PubMedCrossRef
62.
go back to reference Gershwin ME, Mackay IR: The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology. 2008, 47: 737-745.PubMedCrossRef Gershwin ME, Mackay IR: The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology. 2008, 47: 737-745.PubMedCrossRef
63.
go back to reference Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME: Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology. 2001, 33: 16-21.PubMedCrossRef Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME: Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology. 2001, 33: 16-21.PubMedCrossRef
64.
go back to reference Prince MI, Ducker SJ, James OF: Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut. 2010, 59: 508-512.PubMedCrossRef Prince MI, Ducker SJ, James OF: Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut. 2010, 59: 508-512.PubMedCrossRef
65.
go back to reference Smyk D, Mytilinaiou MG, Rigopoulou EI, Bogdanos DP: PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. Dis Markers. 2010, 29: 337-344.PubMedCentralPubMedCrossRef Smyk D, Mytilinaiou MG, Rigopoulou EI, Bogdanos DP: PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. Dis Markers. 2010, 29: 337-344.PubMedCentralPubMedCrossRef
67.
go back to reference Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Suen YF, Kurth MJ, Nantz MH, Ansari AA: Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol. 2005, 174: 5874-5883.PubMedCrossRef Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Suen YF, Kurth MJ, Nantz MH, Ansari AA: Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol. 2005, 174: 5874-5883.PubMedCrossRef
69.
go back to reference Smyk D, Cholongitas E, Kriese S, Rigopoulou EI, Bogdanos DP: Primary biliary cirrhosis: family stories. Autoimmune Dis. 2011, 2011: 189585-PubMedCentralPubMed Smyk D, Cholongitas E, Kriese S, Rigopoulou EI, Bogdanos DP: Primary biliary cirrhosis: family stories. Autoimmune Dis. 2011, 2011: 189585-PubMedCentralPubMed
70.
go back to reference Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP: Autoimmunity and Environment: Am I at risk?. Clin Rev Allergy Immunol. 2011 Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP: Autoimmunity and Environment: Am I at risk?. Clin Rev Allergy Immunol. 2011
71.
go back to reference Smyk DS, Bogdanos DP, Kriese S, Billinis C, Burroughs AK, Rigopoulou EI: Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside. Clin Res Hepatol Gastroenterol. 2011 Smyk DS, Bogdanos DP, Kriese S, Billinis C, Burroughs AK, Rigopoulou EI: Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside. Clin Res Hepatol Gastroenterol. 2011
72.
go back to reference Siegel SM, Selmi C, Dottorini L, Antelmi M, Zuin M, Lanfredini M, Gershwin ME: Late-onset autoimmunity: the paradigm of primary biliary cirrhosis--a mini-review. Gerontology. 2008, 54: 193-201.PubMedCrossRef Siegel SM, Selmi C, Dottorini L, Antelmi M, Zuin M, Lanfredini M, Gershwin ME: Late-onset autoimmunity: the paradigm of primary biliary cirrhosis--a mini-review. Gerontology. 2008, 54: 193-201.PubMedCrossRef
73.
go back to reference Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE: Aging, immunity and cancer. Curr Opin Immunol. 2004, 16: 151-156.PubMedCrossRef Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE: Aging, immunity and cancer. Curr Opin Immunol. 2004, 16: 151-156.PubMedCrossRef
74.
go back to reference Prelog M: Aging of the immune system: a risk factor for autoimmunity?. Autoimmun Rev. 2006, 5: 136-139.PubMedCrossRef Prelog M: Aging of the immune system: a risk factor for autoimmunity?. Autoimmun Rev. 2006, 5: 136-139.PubMedCrossRef
75.
go back to reference Fulop T, Larbi A, Dupuis G, Pawelec G: Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthritis Res Ther. 2003, 5: 290-302.PubMedCentralPubMedCrossRef Fulop T, Larbi A, Dupuis G, Pawelec G: Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthritis Res Ther. 2003, 5: 290-302.PubMedCentralPubMedCrossRef
76.
go back to reference Vallejo AN: CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev. 2005, 205: 158-169.PubMedCrossRef Vallejo AN: CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev. 2005, 205: 158-169.PubMedCrossRef
77.
go back to reference Vallejo AN: Immunological hurdles of ageing: Indispensable research of the human model. Ageing Res Rev. 2011 Vallejo AN: Immunological hurdles of ageing: Indispensable research of the human model. Ageing Res Rev. 2011
78.
79.
go back to reference Azuma M, Phillips JH, Lanier LL: CD28 co-stimulation of T-cell-mediated cytotoxicity. Int J Cancer Suppl. 1992, 7: 33-35.PubMed Azuma M, Phillips JH, Lanier LL: CD28 co-stimulation of T-cell-mediated cytotoxicity. Int J Cancer Suppl. 1992, 7: 33-35.PubMed
80.
go back to reference Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM: Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol. 2001, 75: 12182-12187.PubMedCentralPubMedCrossRef Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM: Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol. 2001, 75: 12182-12187.PubMedCentralPubMedCrossRef
81.
82.
go back to reference Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D: Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis. 2003, 35: 801-805.PubMedCrossRef Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D: Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis. 2003, 35: 801-805.PubMedCrossRef
83.
go back to reference Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou E, Montalto P, Davies ET, Burroughs AK, Vergani D: Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol. 2004, 40: 31-39.PubMedCrossRef Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou E, Montalto P, Davies ET, Burroughs AK, Vergani D: Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol. 2004, 40: 31-39.PubMedCrossRef
84.
go back to reference Bogdanos DP, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, Burroughs AK, Vergani D: Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol. 2004, 39: 981-987.PubMedCrossRef Bogdanos DP, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, Burroughs AK, Vergani D: Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol. 2004, 39: 981-987.PubMedCrossRef
85.
go back to reference Bogdanos DP, Baum H, Sharma UC, Grasso A, Ma Y, Burroughs AK, Vergani D: Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol. 2002, 36: 14-21.PubMedCrossRef Bogdanos DP, Baum H, Sharma UC, Grasso A, Ma Y, Burroughs AK, Vergani D: Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol. 2002, 36: 14-21.PubMedCrossRef
86.
go back to reference Bogdanos DP, Baum H, Vergani D, Burroughs AK: The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers. 2010, 29: 301-311.PubMedCentralPubMedCrossRef Bogdanos DP, Baum H, Vergani D, Burroughs AK: The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers. 2010, 29: 301-311.PubMedCentralPubMedCrossRef
87.
go back to reference Bogdanos DP, Vergani D: Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int. 2006, 26: 633-635.PubMedCrossRef Bogdanos DP, Vergani D: Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int. 2006, 26: 633-635.PubMedCrossRef
88.
go back to reference Bogdanos DP, Vergani D: Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol. 2009, 36: 30-39.PubMedCrossRef Bogdanos DP, Vergani D: Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol. 2009, 36: 30-39.PubMedCrossRef
89.
90.
go back to reference Selmi C, Gershwin ME: The role of environmental factors in primary biliary cirrhosis. Trends Immunol. 2009, 30: 415-420.PubMedCrossRef Selmi C, Gershwin ME: The role of environmental factors in primary biliary cirrhosis. Trends Immunol. 2009, 30: 415-420.PubMedCrossRef
91.
go back to reference Shimoda S, Nakamura M, Shigematsu H, Tanimoto H, Gushima T, Gershwin ME, Ishibashi H: Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology. 2000, 31: 1212-1216.PubMedCrossRef Shimoda S, Nakamura M, Shigematsu H, Tanimoto H, Gushima T, Gershwin ME, Ishibashi H: Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology. 2000, 31: 1212-1216.PubMedCrossRef
92.
go back to reference Bernuzzi F, Fenoglio D, Battaglia F, Fravega M, Gershwin ME, Indiveri F, Ansari AA, Podda M, Invernizzi P, Filaci G: Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun. 2010, 35: 176-180.PubMedCentralPubMedCrossRef Bernuzzi F, Fenoglio D, Battaglia F, Fravega M, Gershwin ME, Indiveri F, Ansari AA, Podda M, Invernizzi P, Filaci G: Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun. 2010, 35: 176-180.PubMedCentralPubMedCrossRef
93.
go back to reference Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo JA, Lepelletier Y, Gabet AS, Hermine O: The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun Rev. 2010, 9: 646-651.PubMedCrossRef Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo JA, Lepelletier Y, Gabet AS, Hermine O: The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun Rev. 2010, 9: 646-651.PubMedCrossRef
94.
go back to reference Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI: Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br J Rheumatol. 1996, 35: 732-737.PubMedCrossRef Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI: Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br J Rheumatol. 1996, 35: 732-737.PubMedCrossRef
95.
go back to reference Beier F, Balabanov S, Amberger CC, Hartmann U, Manger K, Dietz K, Kotter I, Brummendorf TH: Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH. Lupus. 2007, 16: 955-962.PubMedCrossRef Beier F, Balabanov S, Amberger CC, Hartmann U, Manger K, Dietz K, Kotter I, Brummendorf TH: Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH. Lupus. 2007, 16: 955-962.PubMedCrossRef
96.
go back to reference Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM: Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum. 2008, 58: 990-1000.PubMedCentralPubMedCrossRef Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM: Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum. 2008, 58: 990-1000.PubMedCentralPubMedCrossRef
97.
go back to reference Honda M, Mengesha E, Albano S, Nichols WS, Wallace DJ, Metzger A, Klinenberg JR, Linker-Israeli M: Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol. 2001, 99: 211-221.PubMedCrossRef Honda M, Mengesha E, Albano S, Nichols WS, Wallace DJ, Metzger A, Klinenberg JR, Linker-Israeli M: Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol. 2001, 99: 211-221.PubMedCrossRef
98.
go back to reference Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM: T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 2000, 97: 9203-9208.PubMedCentralPubMedCrossRef Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM: T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 2000, 97: 9203-9208.PubMedCentralPubMedCrossRef
99.
go back to reference Kurosaka D, Yasuda J, Yoshida K, Yokoyama T, Ozawa Y, Obayashi Y, Kingetsu I, Saito S, Yamada A: Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients. Lupus. 2003, 12: 591-599.PubMedCrossRef Kurosaka D, Yasuda J, Yoshida K, Yokoyama T, Ozawa Y, Obayashi Y, Kingetsu I, Saito S, Yamada A: Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients. Lupus. 2003, 12: 591-599.PubMedCrossRef
100.
go back to reference Kurosaka D, Yasuda J, Yoshida K, Yoneda A, Yasuda C, Kingetsu I, Toyokawa Y, Yokoyama T, Saito S, Yamada A: Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus. J Rheumatol. 2006, 33: 1102-1107.PubMed Kurosaka D, Yasuda J, Yoshida K, Yoneda A, Yasuda C, Kingetsu I, Toyokawa Y, Yokoyama T, Saito S, Yamada A: Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus. J Rheumatol. 2006, 33: 1102-1107.PubMed
101.
go back to reference MacIntyre A, Brouilette SW, Lamb K, Radhakrishnan K, McGlynn L, Chee MM, Parkinson EK, Freeman D, Madhok R, Shiels PG: Association of increased telomere lengths in limited scleroderma, with a lack of age-related telomere erosion. Ann Rheum Dis. 2008, 67: 1780-1782.PubMedCrossRef MacIntyre A, Brouilette SW, Lamb K, Radhakrishnan K, McGlynn L, Chee MM, Parkinson EK, Freeman D, Madhok R, Shiels PG: Association of increased telomere lengths in limited scleroderma, with a lack of age-related telomere erosion. Ann Rheum Dis. 2008, 67: 1780-1782.PubMedCrossRef
102.
go back to reference Schonland SO, Lopez C, Widmann T, Zimmer J, Bryl E, Goronzy JJ, Weyand CM: Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA. 2003, 100: 13471-13476.PubMedCentralPubMedCrossRef Schonland SO, Lopez C, Widmann T, Zimmer J, Bryl E, Goronzy JJ, Weyand CM: Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA. 2003, 100: 13471-13476.PubMedCentralPubMedCrossRef
103.
go back to reference Wu CH, Hsieh SC, Li KJ, Lu MC, Yu CL: Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity. Lupus. 2007, 16: 265-272.PubMedCrossRef Wu CH, Hsieh SC, Li KJ, Lu MC, Yu CL: Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity. Lupus. 2007, 16: 265-272.PubMedCrossRef
104.
go back to reference Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y: Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. Hepatology. 2008, 48: 186-195.PubMedCrossRef Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y: Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. Hepatology. 2008, 48: 186-195.PubMedCrossRef
105.
go back to reference Katayama Y, Kohriyama K: Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases. J Rheumatol. 2001, 28: 288-291.PubMed Katayama Y, Kohriyama K: Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases. J Rheumatol. 2001, 28: 288-291.PubMed
106.
go back to reference Tarhan F, Vural F, Kosova B, Aksu K, Cogulu O, Keser G, Gunduz C, Tombuloglu M, Oder G, Karaca E, Doganavsargil E: Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis. Rheumatol Int. 2008, 28: 579-583.PubMedCrossRef Tarhan F, Vural F, Kosova B, Aksu K, Cogulu O, Keser G, Gunduz C, Tombuloglu M, Oder G, Karaca E, Doganavsargil E: Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis. Rheumatol Int. 2008, 28: 579-583.PubMedCrossRef
107.
go back to reference Prelog M, Schwarzenbrunner N, Sailer-Hock M, Kern H, Klein-Franke A, Ausserlechner MJ, Koppelstaetter C, Brunner A, Duftner C, Dejaco C: Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum. 2008, 58: 2153-2162.PubMedCrossRef Prelog M, Schwarzenbrunner N, Sailer-Hock M, Kern H, Klein-Franke A, Ausserlechner MJ, Koppelstaetter C, Brunner A, Duftner C, Dejaco C: Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum. 2008, 58: 2153-2162.PubMedCrossRef
108.
go back to reference Kurosaka D, Yasuda J, Kingetsu I, Yasuda C, Yoshida K, Toyokawa Y, Yokoyama T, Yamada A: Two cases of adult Still's disease with abnormally high level of telomerase activity in peripheral blood mononuclear cells. Mod Rheumatol. 2004, 14: 394-398.PubMedCrossRef Kurosaka D, Yasuda J, Kingetsu I, Yasuda C, Yoshida K, Toyokawa Y, Yokoyama T, Yamada A: Two cases of adult Still's disease with abnormally high level of telomerase activity in peripheral blood mononuclear cells. Mod Rheumatol. 2004, 14: 394-398.PubMedCrossRef
109.
go back to reference Vogt S, Iking-Konert C, Hug F, Andrassy K, Hansch GM: Shortening of telomeres: Evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int. 2003, 63: 2144-2151.PubMedCrossRef Vogt S, Iking-Konert C, Hug F, Andrassy K, Hansch GM: Shortening of telomeres: Evidence for replicative senescence of T cells derived from patients with Wegener's granulomatosis. Kidney Int. 2003, 63: 2144-2151.PubMedCrossRef
110.
go back to reference Collado M, Blasco MA, Serrano M: Cellular senescence in cancer and aging. Cell. 2007, 130: 223-233.PubMedCrossRef Collado M, Blasco MA, Serrano M: Cellular senescence in cancer and aging. Cell. 2007, 130: 223-233.PubMedCrossRef
111.
go back to reference Sasaki M, Nakanuma Y: Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosis. Hepat Res Treat. 2010, 2010: 205128-PubMedCentralPubMed Sasaki M, Nakanuma Y: Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosis. Hepat Res Treat. 2010, 2010: 205128-PubMedCentralPubMed
112.
go back to reference Sasaki M, Ikeda H, Haga H, Manabe T, Nakanuma Y: Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss. J Pathol. 2005, 205: 451-459.PubMedCrossRef Sasaki M, Ikeda H, Haga H, Manabe T, Nakanuma Y: Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss. J Pathol. 2005, 205: 451-459.PubMedCrossRef
113.
go back to reference Sasaki M, Ikeda H, Nakanuma Y: Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. J Autoimmun. 2008, 31: 73-78.PubMedCrossRef Sasaki M, Ikeda H, Nakanuma Y: Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. J Autoimmun. 2008, 31: 73-78.PubMedCrossRef
114.
go back to reference Sasaki M, Ikeda H, Sato Y, Nakanuma Y: Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am J Pathol. 2006, 169: 831-845.PubMedCentralPubMedCrossRef Sasaki M, Ikeda H, Sato Y, Nakanuma Y: Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am J Pathol. 2006, 169: 831-845.PubMedCentralPubMedCrossRef
115.
go back to reference Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H, Alpini G: Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology. 2007, 132: 415-431.PubMedCrossRef Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H, Alpini G: Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology. 2007, 132: 415-431.PubMedCrossRef
116.
go back to reference Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y: Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology. 2005, 41: 506-516.PubMedCrossRef Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y: Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology. 2005, 41: 506-516.PubMedCrossRef
117.
go back to reference Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y: Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis. J Hepatol. 2010, 53: 318-325.PubMedCrossRef Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y: Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis. J Hepatol. 2010, 53: 318-325.PubMedCrossRef
118.
go back to reference Tsuneyama K, Harada K, Yasoshima M, Hiramatsu K, Mackay CR, Mackay IR, Gershwin ME, Nakanuma Y: Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis. J Pathol. 2001, 193: 102-109.PubMedCrossRef Tsuneyama K, Harada K, Yasoshima M, Hiramatsu K, Mackay CR, Mackay IR, Gershwin ME, Nakanuma Y: Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis. J Pathol. 2001, 193: 102-109.PubMedCrossRef
119.
go back to reference Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y: Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Lab Invest. 2010, 90: 835-843.PubMedCrossRef Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y: Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Lab Invest. 2010, 90: 835-843.PubMedCrossRef
122.
go back to reference White E, Lowe SW: Eating to exit: autophagy-enabled senescence revealed. Genes Dev. 2009, 23: 784-787.PubMedCrossRef White E, Lowe SW: Eating to exit: autophagy-enabled senescence revealed. Genes Dev. 2009, 23: 784-787.PubMedCrossRef
124.
go back to reference Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M: The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 2010, 6: 280-289.PubMedCrossRef Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M: The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 2010, 6: 280-289.PubMedCrossRef
125.
go back to reference Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US, Herrmann M: Clearance deficiency--a potential link between infections and autoimmunity. Autoimmun Rev. 2008, 8: 5-8.PubMedCrossRef Schulze C, Munoz LE, Franz S, Sarter K, Chaurio RA, Gaipl US, Herrmann M: Clearance deficiency--a potential link between infections and autoimmunity. Autoimmun Rev. 2008, 8: 5-8.PubMedCrossRef
126.
go back to reference Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 2003, 113: 717-730.PubMedCrossRef Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 2003, 113: 717-730.PubMedCrossRef
127.
go back to reference Savill J: Apoptosis in resolution of inflammation. J Leukoc Biol. 1997, 61: 375-380.PubMed Savill J: Apoptosis in resolution of inflammation. J Leukoc Biol. 1997, 61: 375-380.PubMed
128.
go back to reference Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I: Immunosuppressive effects of apoptotic cells. Nature. 1997, 390: 350-351.PubMedCrossRef Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I: Immunosuppressive effects of apoptotic cells. Nature. 1997, 390: 350-351.PubMedCrossRef
129.
go back to reference Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR: Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998, 41: 1241-1250.PubMedCrossRef Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR: Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998, 41: 1241-1250.PubMedCrossRef
130.
go back to reference Rosen A, Casciola-Rosen L: Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 1999, 6: 6-12.PubMedCrossRef Rosen A, Casciola-Rosen L: Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 1999, 6: 6-12.PubMedCrossRef
131.
go back to reference Svensson B: Occurrence of deficient monocyte yeast cell phagocytosis in presence of rheumatic sera. Scand J Rheumatol Suppl. 1980, 31: 21-27.PubMed Svensson B: Occurrence of deficient monocyte yeast cell phagocytosis in presence of rheumatic sera. Scand J Rheumatol Suppl. 1980, 31: 21-27.PubMed
132.
go back to reference Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, Huebert RC, van de Water J, LaRusso NF, Gershwin ME: T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun. 2006, 27: 232-241.PubMedCrossRef Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, Huebert RC, van de Water J, LaRusso NF, Gershwin ME: T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun. 2006, 27: 232-241.PubMedCrossRef
133.
go back to reference Heyder P, Bekeredjian-Ding I, Parcina M, Blank N, Ho AD, Herrmann M, Lorenz HM, Heeg K, Schiller M: Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha. Autoimmunity. 2007, 40: 331-332.PubMedCrossRef Heyder P, Bekeredjian-Ding I, Parcina M, Blank N, Ho AD, Herrmann M, Lorenz HM, Heeg K, Schiller M: Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha. Autoimmunity. 2007, 40: 331-332.PubMedCrossRef
134.
go back to reference Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, Ansari AA, Coppel RL, Worman HJ, Gores GJ, Gershwin ME: Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology. 2010, 52: 987-998.PubMedCentralPubMedCrossRef Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, Ansari AA, Coppel RL, Worman HJ, Gores GJ, Gershwin ME: Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology. 2010, 52: 987-998.PubMedCentralPubMedCrossRef
135.
go back to reference Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, Van de Water J, Gershwin ME: Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. 2009, 49: 871-879.PubMedCentralPubMedCrossRef Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, Van de Water J, Gershwin ME: Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. 2009, 49: 871-879.PubMedCentralPubMedCrossRef
136.
go back to reference Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A: Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 2001, 108: 223-232.PubMedCentralPubMedCrossRef Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A: Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 2001, 108: 223-232.PubMedCentralPubMedCrossRef
137.
go back to reference Radic M, Marion T, Monestier M: Nucleosomes are exposed at the cell surface in apoptosis. J Immunol. 2004, 172: 6692-6700.PubMedCrossRef Radic M, Marion T, Monestier M: Nucleosomes are exposed at the cell surface in apoptosis. J Immunol. 2004, 172: 6692-6700.PubMedCrossRef
138.
go back to reference Schiller M, Bekeredjian-Ding I, Heyder P, Blank N, Ho AD, Lorenz HM: Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 2008, 15: 183-191.PubMedCrossRef Schiller M, Bekeredjian-Ding I, Heyder P, Blank N, Ho AD, Lorenz HM: Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 2008, 15: 183-191.PubMedCrossRef
139.
go back to reference Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M: Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002, 46: 191-201.PubMedCrossRef Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M: Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002, 46: 191-201.PubMedCrossRef
140.
go back to reference Hepburn AL, Lampert IA, Boyle JJ, Horncastle D, Ng WF, Layton M, Vyse TJ, Botto M, Mason JC: In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann Rheum Dis. 2007, 66: 1106-1109.PubMedCentralPubMedCrossRef Hepburn AL, Lampert IA, Boyle JJ, Horncastle D, Ng WF, Layton M, Vyse TJ, Botto M, Mason JC: In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann Rheum Dis. 2007, 66: 1106-1109.PubMedCentralPubMedCrossRef
141.
go back to reference Kuhn A, Herrmann M, Kleber S, Beckmann-Welle M, Fehsel K, Martin-Villalba A, Lehmann P, Ruzicka T, Krammer PH, Kolb-Bachofen V: Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum. 2006, 54: 939-950.PubMedCrossRef Kuhn A, Herrmann M, Kleber S, Beckmann-Welle M, Fehsel K, Martin-Villalba A, Lehmann P, Ruzicka T, Krammer PH, Kolb-Bachofen V: Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum. 2006, 54: 939-950.PubMedCrossRef
142.
go back to reference Lorenz HM, Grunke M, Hieronymus T, Herrmann M, Kuhnel A, Manger B, Kalden JR: In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum. 1997, 40: 306-317.PubMedCrossRef Lorenz HM, Grunke M, Hieronymus T, Herrmann M, Kuhnel A, Manger B, Kalden JR: In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum. 1997, 40: 306-317.PubMedCrossRef
143.
go back to reference Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K: Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology. 1997, 25: 1077-1084.PubMedCrossRef Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K: Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology. 1997, 25: 1077-1084.PubMedCrossRef
144.
go back to reference Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H: Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch. 1996, 429: 119-129.PubMed Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H: Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch. 1996, 429: 119-129.PubMed
145.
go back to reference Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM: Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005, 42: 1194-1202.PubMedCentralPubMedCrossRef Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM: Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005, 42: 1194-1202.PubMedCentralPubMedCrossRef
146.
go back to reference Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK: M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol. 1993, 17: 408-414.PubMedCrossRef Butler P, Valle F, Hamilton-Miller JM, Brumfitt W, Baum H, Burroughs AK: M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol. 1993, 17: 408-414.PubMedCrossRef
147.
go back to reference Varyani FK, West J, Card TR: An increased risk of Urinary Tract Infection precedes development of Primary Biliary Cirrhosis. BMC Gastroenterol. 2011, 11: 95-PubMedCentralPubMedCrossRef Varyani FK, West J, Card TR: An increased risk of Urinary Tract Infection precedes development of Primary Biliary Cirrhosis. BMC Gastroenterol. 2011, 11: 95-PubMedCentralPubMedCrossRef
148.
go back to reference Matthews SJ, Lancaster JW: Urinary Tract Infections in the Elderly Population. Am J Geriatr Pharmacother. 2011 Matthews SJ, Lancaster JW: Urinary Tract Infections in the Elderly Population. Am J Geriatr Pharmacother. 2011
149.
go back to reference Hopf U, Moller B, Stemerowicz R, Lobeck H, Rodloff A, Freudenberg M, Galanos C, Huhn D: Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet. 1989, 2: 1419-1422.PubMedCrossRef Hopf U, Moller B, Stemerowicz R, Lobeck H, Rodloff A, Freudenberg M, Galanos C, Huhn D: Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet. 1989, 2: 1419-1422.PubMedCrossRef
150.
go back to reference Vergani D, Bogdanos DP, Baum H: Unusual suspects in primary biliary cirrhosis. Hepatology. 2004, 39: 38-41.PubMedCrossRef Vergani D, Bogdanos DP, Baum H: Unusual suspects in primary biliary cirrhosis. Hepatology. 2004, 39: 38-41.PubMedCrossRef
151.
go back to reference Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G: Pathogenesis of autoimmune hepatitis. Clin Liver Dis. 2002, 6: 727-737.PubMedCrossRef Vergani D, Choudhuri K, Bogdanos DP, Mieli-Vergani G: Pathogenesis of autoimmune hepatitis. Clin Liver Dis. 2002, 6: 727-737.PubMedCrossRef
152.
go back to reference Ma Y, Thomas MG, Okamoto M, Bogdanos DP, Nagl S, Kerkar N, Lopes AR, Muratori L, Lenzi M, Bianchi FB: Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol. 2002, 169: 277-285.PubMedCrossRef Ma Y, Thomas MG, Okamoto M, Bogdanos DP, Nagl S, Kerkar N, Lopes AR, Muratori L, Lenzi M, Bianchi FB: Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol. 2002, 169: 277-285.PubMedCrossRef
153.
go back to reference Gregorio GV, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P, Garson J, Bogdanos DP, Vegnente A, Mieli-Vergani G, Vergani D: Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol. 2003, 133: 404-413.PubMedCentralPubMedCrossRef Gregorio GV, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P, Garson J, Bogdanos DP, Vegnente A, Mieli-Vergani G, Vergani D: Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol. 2003, 133: 404-413.PubMedCentralPubMedCrossRef
154.
go back to reference Gregorio GV, Choudhuri K, Ma Y, Vegnente A, Mieli-Vergani G, Vergani D: Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol. 1999, 162: 1802-1810.PubMed Gregorio GV, Choudhuri K, Ma Y, Vegnente A, Mieli-Vergani G, Vergani D: Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol. 1999, 162: 1802-1810.PubMed
155.
go back to reference Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, Bianchi F, Williams R, Mieli-Vergani G, Vergani D: Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol. 2003, 170: 1481-1489.PubMedCrossRef Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, Bianchi F, Williams R, Mieli-Vergani G, Vergani D: Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol. 2003, 170: 1481-1489.PubMedCrossRef
156.
go back to reference Bogdanos DP, Muratori L, Bianchi FB, Vergani D: Hepatitis C virus and autoimmunity. Hepatology. 2000, 31: 1380-PubMedCrossRef Bogdanos DP, Muratori L, Bianchi FB, Vergani D: Hepatitis C virus and autoimmunity. Hepatology. 2000, 31: 1380-PubMedCrossRef
157.
go back to reference Bogdanos DP, Dalekos GN: Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s. Curr Med Chem. 2008, 15: 2285-2292.PubMedCrossRef Bogdanos DP, Dalekos GN: Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s. Curr Med Chem. 2008, 15: 2285-2292.PubMedCrossRef
158.
go back to reference Bogdanos DP, McFarlane IG: Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol. 2003, 39: 860-863.PubMedCrossRef Bogdanos DP, McFarlane IG: Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol. 2003, 39: 860-863.PubMedCrossRef
159.
go back to reference Bogdanos DP, Lenzi M, Okamoto M, Rigopoulou EI, Muratori P, Ma Y, Muratori L, Tsantoulas D, Mieli- Vergani G, Bianchi FB, Vergani D: Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol. 2004, 17: 83-92.PubMed Bogdanos DP, Lenzi M, Okamoto M, Rigopoulou EI, Muratori P, Ma Y, Muratori L, Tsantoulas D, Mieli- Vergani G, Bianchi FB, Vergani D: Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol. 2004, 17: 83-92.PubMed
160.
go back to reference Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, Mieli-Vergani G, Bianchi FB, Vergani D: Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol. 2005, 3: 595-603.PubMedCrossRef Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, Mieli-Vergani G, Bianchi FB, Vergani D: Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol. 2005, 3: 595-603.PubMedCrossRef
161.
go back to reference Baum H: Nature of the mitochondrial antigens of primary biliary cirrhosis and their possible relationships to the etiology of the disease. Semin Liver Dis. 1989, 9: 117-123.PubMedCrossRef Baum H: Nature of the mitochondrial antigens of primary biliary cirrhosis and their possible relationships to the etiology of the disease. Semin Liver Dis. 1989, 9: 117-123.PubMedCrossRef
162.
go back to reference Butler P, Hamilton-Miller J, Baum H, Burroughs AK: Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?. Biochem Mol Biol Int. 1995, 35: 473-485.PubMed Butler P, Hamilton-Miller J, Baum H, Burroughs AK: Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?. Biochem Mol Biol Int. 1995, 35: 473-485.PubMed
163.
go back to reference Baum H, Bogdanos DP, Vergani D: Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope. J Hepatol. 2001, 34: 785-787.PubMedCrossRef Baum H, Bogdanos DP, Vergani D: Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope. J Hepatol. 2001, 34: 785-787.PubMedCrossRef
164.
go back to reference Mayo I, Arizti P, Pares A, Oliva J, Doforno RA, de Sagarra MR, Rodes J, Castano JG: Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J Hepatol. 2000, 33: 528-536.PubMedCrossRef Mayo I, Arizti P, Pares A, Oliva J, Doforno RA, de Sagarra MR, Rodes J, Castano JG: Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J Hepatol. 2000, 33: 528-536.PubMedCrossRef
165.
go back to reference Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y: HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med. 1995, 181: 1835-1845.PubMedCrossRef Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y: HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med. 1995, 181: 1835-1845.PubMedCrossRef
166.
go back to reference Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, Keeffe EB, Roche TE, Gershwin ME: Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest. 1998, 102: 1831-1840.PubMedCentralPubMedCrossRef Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, Keeffe EB, Roche TE, Gershwin ME: Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest. 1998, 102: 1831-1840.PubMedCentralPubMedCrossRef
167.
go back to reference Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, Vlachogiannakos J, Ma Y, Burroughs AK, Vergani D: Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology. 2005, 42: 458-465.PubMedCrossRef Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, Vlachogiannakos J, Ma Y, Burroughs AK, Vergani D: Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology. 2005, 42: 458-465.PubMedCrossRef
168.
go back to reference Bernier M, Njomnang Soh P, Lochet A, Prots L, Felice R, Senescau A, Fabre R, Philippon A: [Lactobacillus delbrueckii: Probable agent of urinary tract infections in very old women.]. Pathol Biol (Paris). 2010 Bernier M, Njomnang Soh P, Lochet A, Prots L, Felice R, Senescau A, Fabre R, Philippon A: [Lactobacillus delbrueckii: Probable agent of urinary tract infections in very old women.]. Pathol Biol (Paris). 2010
169.
170.
go back to reference Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Kenny TP, Van De Water J, Nantz MH: Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 2003, 38: 1250-1257.PubMedCrossRef Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Kenny TP, Van De Water J, Nantz MH: Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 2003, 38: 1250-1257.PubMedCrossRef
171.
go back to reference Mattner J, Savage PB, Leung P, Oertelt SS, Wang V, Trivedi O, Scanlon ST, Pendem K, Teyton L, Hart J: Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe. 2008, 3: 304-315.PubMedCentralPubMedCrossRef Mattner J, Savage PB, Leung P, Oertelt SS, Wang V, Trivedi O, Scanlon ST, Pendem K, Teyton L, Hart J: Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe. 2008, 3: 304-315.PubMedCentralPubMedCrossRef
172.
go back to reference Stellon AJ, Williams R: Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J. 1986, 293: 297-298.CrossRef Stellon AJ, Williams R: Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J. 1986, 293: 297-298.CrossRef
173.
174.
go back to reference Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A, Sferra R, Ginanni-Corradini S, Mancino MG, Maggioni M: Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol. 2004, 41: 905-912.PubMedCrossRef Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A, Sferra R, Ginanni-Corradini S, Mancino MG, Maggioni M: Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol. 2004, 41: 905-912.PubMedCrossRef
175.
go back to reference Alvaro D, Mancino MG, Onori P, Franchitto A, Alpini G, Francis H, Glaser S, Gaudio E: Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol. 2006, 12: 3537-3545.PubMedCentralPubMed Alvaro D, Mancino MG, Onori P, Franchitto A, Alpini G, Francis H, Glaser S, Gaudio E: Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol. 2006, 12: 3537-3545.PubMedCentralPubMed
176.
go back to reference Alvaro D, Onori P, Metalli VD, Svegliati-Baroni G, Folli F, Franchitto A, Alpini G, Mancino MG, Attili AF, Gaudio E: Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology. 2002, 36: 297-304.PubMedCrossRef Alvaro D, Onori P, Metalli VD, Svegliati-Baroni G, Folli F, Franchitto A, Alpini G, Mancino MG, Attili AF, Gaudio E: Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology. 2002, 36: 297-304.PubMedCrossRef
177.
go back to reference Guattery JM, Faloon WW: Effect of estradiol upon serum enzymes in primary biliary cirrhosis. Hepatology. 1987, 7: 737-742.PubMedCrossRef Guattery JM, Faloon WW: Effect of estradiol upon serum enzymes in primary biliary cirrhosis. Hepatology. 1987, 7: 737-742.PubMedCrossRef
178.
go back to reference Mason AL: The evidence supports a viral aetiology for primary biliary cirrhosis. J Hepatol. 2011, 54: 1312-1314.PubMedCrossRef Mason AL: The evidence supports a viral aetiology for primary biliary cirrhosis. J Hepatol. 2011, 54: 1312-1314.PubMedCrossRef
179.
go back to reference Mason AL, Zhang G: Linking human beta retrovirus infection with primary biliary cirrhosis. Gastroenterol Clin Biol. 2010, 34: 359-366.PubMedCrossRef Mason AL, Zhang G: Linking human beta retrovirus infection with primary biliary cirrhosis. Gastroenterol Clin Biol. 2010, 34: 359-366.PubMedCrossRef
180.
go back to reference Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL: Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis. Liver Int. 2010, 30: 871-877.PubMedCrossRef Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL: Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis. Liver Int. 2010, 30: 871-877.PubMedCrossRef
181.
go back to reference Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A: Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet. 1998, 351: 1620-1624.PubMedCrossRef Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, Sander DM, Shoenfeld Y, Ahmed A: Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet. 1998, 351: 1620-1624.PubMedCrossRef
182.
go back to reference Mason A, Xu L, Shen Z, Fodera B, Joplin R, Neuberger J, O'Donnell B: Patients with primary biliary cirrhosis make anti-viral and anti-mitochondrial antibodies to mouse mammary tumor virus. Gastroenterology. 2004, 127: 1863-1864. author reply 1864-1865PubMedCrossRef Mason A, Xu L, Shen Z, Fodera B, Joplin R, Neuberger J, O'Donnell B: Patients with primary biliary cirrhosis make anti-viral and anti-mitochondrial antibodies to mouse mammary tumor virus. Gastroenterology. 2004, 127: 1863-1864. author reply 1864-1865PubMedCrossRef
183.
go back to reference Xu L, Shen Z, Guo L, Fodera B, Keogh A, Joplin R, O'Donnell B, Aitken J, Carman W, Neuberger J, Mason A: Does a betaretrovirus infection trigger primary biliary cirrhosis?. Proc Natl Acad Sci USA. 2003, 100: 8454-8459.PubMedCentralPubMedCrossRef Xu L, Shen Z, Guo L, Fodera B, Keogh A, Joplin R, O'Donnell B, Aitken J, Carman W, Neuberger J, Mason A: Does a betaretrovirus infection trigger primary biliary cirrhosis?. Proc Natl Acad Sci USA. 2003, 100: 8454-8459.PubMedCentralPubMedCrossRef
184.
go back to reference Selmi C, Ross SR, Ansari AA, Invernizzi P, Podda M, Coppel RL, Gershwin ME: Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology. 2004, 127: 493-501.PubMedCrossRef Selmi C, Ross SR, Ansari AA, Invernizzi P, Podda M, Coppel RL, Gershwin ME: Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology. 2004, 127: 493-501.PubMedCrossRef
185.
go back to reference Johal H, Scott GM, Jones R, Camaris C, Riordan S, Rawlinson WD: Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J Hepatol. 2009, 50: 548-554.PubMedCrossRef Johal H, Scott GM, Jones R, Camaris C, Riordan S, Rawlinson WD: Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J Hepatol. 2009, 50: 548-554.PubMedCrossRef
186.
go back to reference Sadamoto T, Joplin R, Keogh A, Mason A, Carman W, Neuberger J: Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet. 1998, 352: 1595-1596.PubMedCrossRef Sadamoto T, Joplin R, Keogh A, Mason A, Carman W, Neuberger J: Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet. 1998, 352: 1595-1596.PubMedCrossRef
187.
go back to reference Wasilenko ST, Mason GE, Mason AL: Primary biliary cirrhosis, bacteria and molecular mimicry: what's the molecule and where's the mimic?. Liver Int. 2009, 29: 779-782.PubMedCrossRef Wasilenko ST, Mason GE, Mason AL: Primary biliary cirrhosis, bacteria and molecular mimicry: what's the molecule and where's the mimic?. Liver Int. 2009, 29: 779-782.PubMedCrossRef
188.
go back to reference Mason AL, Farr GH, Xu L, Hubscher SG, Neuberger JM: Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis. Am J Gastroenterol. 2004, 99: 2348-2355.PubMedCrossRef Mason AL, Farr GH, Xu L, Hubscher SG, Neuberger JM: Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis. Am J Gastroenterol. 2004, 99: 2348-2355.PubMedCrossRef
189.
go back to reference Mason AL, Wasilenko ST: Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis. Clin Liver Dis. 2008, 12: 445-460. xiPubMedCrossRef Mason AL, Wasilenko ST: Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis. Clin Liver Dis. 2008, 12: 445-460. xiPubMedCrossRef
190.
go back to reference Mason AL, Lindor KD, Bacon BR, Vincent C, Neuberger JM, Wasilenko ST: Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. Aliment Pharmacol Ther. 2008 Mason AL, Lindor KD, Bacon BR, Vincent C, Neuberger JM, Wasilenko ST: Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. Aliment Pharmacol Ther. 2008
191.
go back to reference Selmi C: The evidence does not support a viral etiology for primary biliary cirrhosis. J Hepatol. 2011, 54: 1315-1316.PubMedCrossRef Selmi C: The evidence does not support a viral etiology for primary biliary cirrhosis. J Hepatol. 2011, 54: 1315-1316.PubMedCrossRef
Metadata
Title
Immunopathogenesis of primary biliary cirrhosis: an old wives' tale
Authors
Daniel S Smyk
Eirini I Rigopoulou
Ana Lleo
Robin D Abeles
Athanasios Mavropoulos
Charalambos Billinis
Pietro Invernizzi
Dimitrios P Bogdanos
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2011
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/1742-4933-8-12

Other articles of this Issue 1/2011

Immunity & Ageing 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.